NEA Management Company, LLC
Q1 2025 13F Holdings
- Locationtimonium, MD
- Num holdings
38
- Value ($000)
$1,298,445
- Date Filed05/14/2025
- Form type13F-HR
- CIK0001512848
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
ACLX ARCELLX INC | COMMON STOCK | 03940C100 | $245.69M | 19 % | 3,745,262 | ||
VRNA VERONA PHARMA PLC | SPONSERED ADS | 925050106 | $170.70M | 13 % | 2,688,565 | ||
RYTM RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $154.14M | 12 % | 2,909,956 | ||
TEM TEMPUS AI INC | CL A | 88023B103 | $126.19M | 10 % | 2,615,979 | ||
COUR COURSERA INC | COM | 22266M104 | $85.70M | 7 % | 12,867,769 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | $71.52M | 6 % | 11,370,376 | ||
YB4P SAVARA INC | COM | 805111101 | $67.79M | 5 % | 24,471,264 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $54.03M | 4 % | 1,587,854 | ||
GLUE MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | $35.69M | 3 % | 7,692,298 | ||
AUPH AURINIA PHARMACEUTICALS INC | COM | 05156V102 | $31.92M | 3 % | 3,969,834 |
Rows Per Page
10
- 10
- 50
- 100